K. Suenaga et al. / Tetrahedron 62 (2006) 7687–7698
7697
0.80 (s, 3H); 13C NMR (67.8 MHz, CDCl3) d 204.6, 175.9,
147.7, 136.0, 135.6, 134.2, 134.1, 131.3, 129.6, 129.1,
127.5, 126.1, 110.6, 98.2, 74.1, 71.0, 66.7, 49.0, 47.9, 47.6,
41.3, 34.6, 27.1, 21.2, 19.3, 19.2, 18.7, 12.5; HRMS (FAB)
calcd for C37H4779BrNaO6Si (M+Na)+ 717.2223, found
717.2234. Compound 41b: TLC, Rf 0.28 (hexane–ether
3:1); [a]2D1 +11.4 (c 0.214, CHCl3); IR (neat) 3437, 1697,
dried (Na2SO4), and concentrated. The residual oil was
purified by column chromatography on silica gel (FL-60D,
2 g, hexane–EtOAc 5:1) to give TBS ether of auriside A
(1.9 mg) as a colorless oil.
To a stirred solution of TBS ether of auriside A (0.9 mg) in
THF (0.06 mL) cooled at 0 ꢁC was added HF$pyridine com-
plex (0.013 mL). The mixture was stirred at room tempera-
ture for 18 h, diluted with saturated aqueous NaHCO3
(2 mL), and extracted with EtOAc (3ꢂ10 mL). The com-
bined extracts were washed with brine (10 mL), dried
(Na2SO4), and concentrated. The residual oil was purified
by column chromatography on silica gel (FL-60D, 1 g, hex-
ane–EtOAc 1:3) followed by HPLC [Develosil ODS-HG-5
(f 4.6ꢂ250 mm), 75% MeOH, flow rate 5 mL minꢀ1, detec-
tion at 215 nm] to give auriside A (1) (0.8 mg, 42% in two
steps) as a colorless oil: TLC, Rf 0.20 (hexane–EtOAc
1
1427, 1261, 1169, 1107, 980 cmꢀ1; H NMR (270 MHz,
CDCl3) d 7.69–7.63 (m, 4H), 7.46–7.33 (m, 6H), 6.70 (dd,
J¼13.5, 10.8 Hz, 1H), 6.40 (d, J¼13.5 Hz, 1H), 6.21 (s,
1H), 6.18 (dd, J¼14.0, 10.8 Hz, 1H), 5.78–5.67 (m, 2H),
5.11 (d, J¼2.7 Hz, 1H), 4.28 (m, 1H), 3.44 (dd, J¼11.9,
2.2 Hz, 1H), 2.56 (q, J¼7.0 Hz, 1H), 2.31–2.24 (m, 2H),
2.05 (s, 3H), 1.86 (dd, J¼11.6, 3.0 Hz, 1H), 1.64–1.50 (m,
2H), 1.27 (m, 1H), 1.25 (d, J¼7.0 Hz, 3H), 1.20 (s, 3H),
1.07 (s, 9H), 0.79 (s, 3H); 13C NMR (67.8 MHz, CDCl3)
d 204.9, 173.3, 147.3, 136.0, 135.6, 135.6, 134.3, 134.1,
131.3, 129.6, 129.6, 129.1, 127.5, 126.3, 110.1, 98.4, 73.8,
71.2, 66.8, 49.3, 48.6, 47.3, 40.8, 34.3, 27.1, 21.1, 19.2,
18.4, 11.4; HRMS (FAB) calcd for C37H4779BrNaO6Si
(M+Na)+ 717.2223, found 717.2200.
1
1:4); [a]2D3 ꢀ31 (c 0.040, MeOH); H NMR (500 MHz,
C6D6) d 6.40 (dd, J¼13.5, 10.9 Hz, 1H), 6.35 (s, 1H), 5.91
(d, J¼13.5 Hz, 1H), 5.63 (dd, J¼15.4, 10.9 Hz, 1H), 5.56
(m, 1H), 5.34 (d, J¼1.5 Hz, 1H), 5.18 (dd, J¼15.4, 6.5 Hz,
1H), 5.04 (d, J¼2.0 Hz, 1H), 4.93 (d, J¼2.5 Hz, 1H), 4.30
(dd, J¼9.5, 3.1 Hz, 1H), 4.26 (m, 1H), 4.24 (dd, J¼9.5,
3.7 Hz, 1H), 4.09 (dq, J¼9.5, 6.2 Hz, 1H), 3.94 (dd,
J¼11.8, 2.0 Hz, 1H), 3.90 (dq, J¼9.5, 6.2 Hz, 1H), 3.68
(dd, J¼3.1, 2.0 Hz, 1H), 3.56 (dd, J¼3.7, 1.5 Hz, 1H),
3.49 (s, 3H), 3.46 (t, J¼9.5 Hz, 1H), 3.31 (s, 3H), 3.26 (s,
3H), 3.16 (t, J¼9.5 Hz, 1H), 3.07 (s, 3H), 2.48 (q,
J¼7.2 Hz, 1H), 2.33 (dd, J¼11.8, 4.4 Hz, 1H), 2.30 (s,
3H), 2.18 (m, 1H), 1.97 (t, J¼12.1 Hz, 1H), 1.82 (m, 1H),
1.81 (m, 1H), 1.43 (d, J¼6.2 Hz, 1H), 1.35 (d, J¼6.2 Hz,
1H), 1.24 (q, J¼11.8 Hz, 1H), 1.14 (s, 3H), 1.05 (s, 3H),
1.03 (td, J¼11.8, 2.5 Hz, 1H), 0.97 (d, J¼7.2 Hz, 1H); 13C
NMR (125 MHz, C6D6) d 203.3, 176.4, 147.5, 136.5,
131.7, 129.2, 126.4, 110.8, 98.6, 98.5, 96.3, 84.4, 83.3,
81.6, 81.5, 79.5, 74.6, 72.1, 71.3, 71.1, 69.1, 68.3, 60.8,
60.7, 58.8, 57.9, 49.3, 48.1, 47.5, 39.8, 31.5, 21.6, 19.5,
18.6, 18.4, 18.1, 12.4; MS (FAB) m/z 827 (M+Na)+.
4.1.33. Aglycon 3. To a stirred solution of a diastereomeric
mixture of enone 41a (2.2 mg, 0.0032 mmol) in THF
(0.5 mL) was added a solution of tetrabutylammonium fluo-
ride (Bu4NF) and acetic acid (0.19 mL, 0.18 mmol for
Bu4NF and 0.19 mmol for acetic acid) prepared from
a 1.0 M solution of Bu4NF in THF (0.85 mL) and acetic
acid (0.050 mL). The mixture was stirred at room tem-
perature for 20 h, diluted with brine (5 mL), and extracted
with ether (3ꢂ4 mL). The combined extracts were dried
(Na2SO4) and concentrated. The residual oil was purified
by column chromatography on silica gel (FL-60D, 0.3 g, tol-
uene–acetone 9:1) to give 3 (1.3 mg, 90%) as a colorless oil.
Using the same procedure as described above, 3 (1.7 mg,
96%) was obtained from 41b (2.7 mg, 0.022 mmol). Com-
pound 3: TLC, Rf 0.35 (benzene–acetone 5:1), 0.37 (hex-
ane–EtOAc 3:1); [a]3D1 +6.7 (c 0.045, MeOH); IR (neat)
3450, 2970, 2860, 1710, 1680, 1610, 1200, 1180, 980,
1
760 cmꢀ1; H NMR (400 MHz, C6D6) d 6.40 (dd, J¼13.7,
4.1.35. Auriside B (2). To a stirred suspension of stannous
chloride (3.1 mg, 0.017 mmol), silver perchlorate (3.4 mg,
10.8 Hz, 1H), 6.32 (d, J¼1.0 Hz, 1H), 5.91 (d, J¼13.7 Hz,
1H), 5.65 (dd, J¼15.1, 10.8 Hz, 1H), 5.57 (m, 1H), 5.19
(dd, J¼15.1, 6.3 Hz, 1H), 4.82 (d, J¼3.0 Hz, 1H), 3.94 (m,
1H), 3.87 (dd, J¼11.8, 2.0 Hz, 1H), 2.47 (q, J¼7.3 Hz,
1H), 2.29 (d, J¼1.0 Hz, 1H), 1.99 (m, 1H), 1.97 (dd,
J¼13.2, 11.7 Hz, 1H), 1.82 (dd, J¼13.2, 2.5 Hz, 1H), 1.53
(m, 1H), 1.14 (s, 3H), 1.08 (s, 3H), 1.07 (m, 1H), 0.98 (d,
J¼7.3 Hz, 3H), 0.81 (dt, J¼3.0, 11.2 Hz, 1H). A signal
due to one proton (5-OH) was not observed; 13C NMR
(125 MHz, CDCl3) d 204.7, 176.1, 148.2, 136.1, 131.3,
129.3, 126.1, 110.8, 98.3, 74.3, 71.1, 64.9, 49.1, 47.8,
47.6, 41.1, 34.3, 21.3, 19.3, 18.6, 12.5; HRMS (ESI) calcd
for C21H2979BrNaO6 (M+Na)+ 479.1045, found 479.1041.
ꢁ
˚
0.017 mmol), and MS 4A (45 mg) in ether (0.2 mL) at 0 C
was added a solution of aglycon 3 (2.3 mg, 0.0050 mmol)
and fluorosugar 8 (5.4 mg, 0.023 mmol) in ether (0.9 mL,
2ꢂ0.05 mL rinse). The mixture was stirred at room temper-
ature for 2 h, diluted with saturated aqueous NaHCO3
(5 mL), and extracted with EtOAc (3ꢂ15 mL). The com-
bined extracts were washed with brine (15 mL), dried
(Na2SO4), and concentrated. The residual oil was purified
by column chromatography on silica gel (FL-60D, 1 g, hex-
ane–EtOAc 1:2) followed by HPLC [Develosil ODS-HG-5
(f 4.6ꢂ250 mm), 55% MeCN, flow rate 5 mL minꢀ1, detec-
tion at 215 nm] to give auriside B (2) (2.3 mg, 68%) as a col-
orless oil: Rf 0.30 (hexane–EtOAc 1:2); [a]1D9 ꢀ27 (c 0.080,
1
4.1.34. Auriside A (1). To a stirred suspension of stannous
chloride (3.1 mg, 0.017 mmol), silver perchlorate (3.3 mg,
MeOH); H NMR (500 MHz, C6D6) d 6.40 (dd, J¼13.5,
10.8 Hz, 1H), 6.35 (s, 1H), 5.91 (d, J¼13.5 Hz, 1H), 5.63
(dd, J¼15.3, 10.8 Hz, 1H), 5.57 (m, 1H), 5.54 (dd, J¼9.5,
3.2 Hz, 1H), 5.20 (dd, J¼15.3, 6.6 Hz, 1H), 5.04 (d,
J¼2.0 Hz, 1H), 4.94 (d, J¼1.9 Hz, 1H), 4.25 (m, 1H), 3.99
(dq, J¼9.5, 6.2 Hz, 1H), 3.94 (dd, J¼11.8, 1.9 Hz, 1H),
3.82 (dd, J¼3.2, 2.0 Hz, 1H), 3.73 (br s, 2H), 3.52 (t,
J¼9.5 Hz, 1H), 3.36 (s, 3H), 3.22 (s, 3H), 2.49 (q,
J¼7.2 Hz, 1H), 2.30 (s, 3H), 2.27 (dd, J¼11.8, 4.4 Hz,
˚
0.016 mmol), and MS 4A (43 mg) in ether (0.2 mL) at
0 ꢁC was added a solution of aglycon 3 (2.2 mg,
0.0048 mmol) and fluorosugar 7 (9.9 mg, 0.021 mmol) in
ether (0.1 mL, 3ꢂ0.05 mL rinse). The mixture was stirred
at room temperature for 24 h, diluted with saturated aqueous
NaHCO3 (3 mL), and extracted with EtOAc (3ꢂ10 mL).
The combined extracts were washed with brine (10 mL),